We Are Weill Cornell Medicine: Dr. Christopher Barbieri
Dr. Christopher Barbieri was the type of kid who would press every button in the house, much to his parents’ chagrin. Ultimately he learned to put that inquisitiveness to good use as a doctor and scientist, and discovered a new form of prostate cancer.
Cancer Research Foundation Awards Prestigious Clinical Investigator Award to Two Weill Cornell Medicine Scientists
Two Weill Cornell Medicine scientists have received the Damon Runyon Cancer Research Clinical Investigator Award for 2016 for their innovative research: Dr. Christopher Barbieri and Dr. Heather Yeo.
Read the full article here.
Dr. Barbieri on SPOP Mutations in Prostate Cancer (OncLive)
Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer genomics, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New-York Presbyterian, discusses the implications of SPOP mutations in patients with prostate cancer.
Christopher E. Barbieri
Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer.
